The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Interpreting the Results of Cost-Effectiveness Studies
Open accessAbstract
In developed nations, health care spending is an increasingly important economic and political issue. The discipline of cost-effectiveness (CE) analysis has developed over several decades as a tool for objectively assessing the value of new medical strategies, by simultaneously examining incremental health benefits in light of incremental costs. The underlying goal of CE research is to allow clinicians and policymakers to make more rational decisions regarding clinical care and resource allocation. This review will provide the reader with an understanding of the theoretical underpinnings of CE analysis, the types of analyses commonly performed and reported in the medical literature, some important strengths and weaknesses of different analytical approaches, and key principles in the interpretation of CE results. Key principles reviewed include the impact of analytic perspective, the importance of proper incremental comparisons, the effect of time horizon, and methods for exploring and describing uncertainty. Illustrative examples from the cardiology literature are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
The estimation of a preference-based measure of health from the SF-36
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,026
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Measurement of health state utilities for economic appraisal
Torrance, G. W. (1986) · Journal of Health Economics · doi:10.1016/0167-6296(86)90020-2 · Cited by 2,203
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
Weinstein, M. C., & Stason, W. B. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961304 · Cited by 2,119
An Introduction to the Bootstrap.
Kimber, A., Efron, B., & Tibshirani, R. J. (1994) · The Statistician · doi:10.2307/2348146 · Cited by 1,245
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
Mauskopf, J. A., Sullivan, S. D., Annemans, L., Caro, J., Mullins, C. D., Nuijten, M., Orlewska, E., Watkins, J., & Trueman, P. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00187.x · Cited by 750
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahé, C., & Wright, T. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044278 · Cited by 671
What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?
Ubel, P. A., Hirth, R. A., Chernew, M. E., & Fendrick, A. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1637 · Cited by 588
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
The Value of Medical Spending in the United States, 1960–2000
Cutler, D. M., Rosen, A. B., & Vijan, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa054744 · Cited by 446
Chen, Y., Jobanputra, P., Barton, P., Bryan, S., Fry-Smith, A., Harris, G., & Taylor, R. (2008) · Health Technology Assessment · doi:10.3310/hta12110 · Cited by 339
High and Rising Health Care Costs. Part 2: Technologic Innovation
Bodenheimer, T. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00012 · Cited by 329
The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators: Results From MADIT
Mushlin, A. I., Hall, W. J., Zwanziger, J., Gajary, E., Andrews, M., Marron, R., Zou, K. H., & Moss, A. J. (1998) · Circulation · doi:10.1161/01.cir.97.21.2129 · Cited by 276
Mark, D. B., Nelson, C. L., Anstrom, K. J., Al-Khatib, S. M., Tsiatis, A. A., Cowper, P. A., Clapp-Channing, N. E., Davidson-Ray, L., Poole, J. E., Johnson, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.581884 · Cited by 265
Cohen, D. J., Bakhai, A., Shi, C., Githiora, L., Lavelle, T., Berezin, R. H., Leon, M. B., Moses, J. W., Carrozza, J. P., Zidar, J. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000136821.99814.43 · Cited by 234
Self-citationMedicare and Cost-Effectiveness Analysis
Neumann, P. J., Rosen, A. B., & Weinstein, M. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsb050564 · Cited by 225
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
Zwanziger, J., Hall, W. J., Dick, A. W., Zhao, H., Mushlin, A. I., Hahn, R. M., Wang, H., Andrews, M. L., Mooney, C., Wang, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.032 · Cited by 221
High and rising health care costs.
Ginsburg, P. Β. (2008) · PubMed · Cited by 200
Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation
Critchfield, G. C., & Willard, K. E. (1986) · Medical Decision Making · doi:10.1177/0272989x8600600205 · Cited by 198
Pharmacoeconomic Analyses Using Discrete Event Simulation
Caro, J. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523040-00003 · Cited by 191
Feldman, A. M., de Lissovoy, G., Bristow, M. R., Saxon, L. A., De Marco, T., Kass, D. A., Boehmer, J., Singh, S., Whellan, D. J., Carson, P., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.033 · Cited by 184
Goldman, D. P., Shang, B., Bhattacharya, J., Garber, A. M., Hurd, M., Joyce, G. F., Lakdawalla, D. N., Panis, C., & Shekelle, P. G. (2005) · Health Affairs · doi:10.1377/hlthaff.w5.r5 · Cited by 178
Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses
Brauer, C. A., Rosen, A. B., Greenberg, D., & Neumann, P. J. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00116.x · Cited by 144
The use of economic evaluations in NHS decision-making: a review and empirical investigation
Williams, I., McIver, S., Moore, D., & Bryan, S. (2008) · Health Technology Assessment · doi:10.3310/hta12070 · Cited by 130
Larsen, G. C., Hallstrom, A. P., McAnulty, J. H., Pinski, S. L., Olarte, A., Sullivan, S. D., Brodsky, M. A., Powell, J. L., Marchant, C., Jennings, C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000015504.57641.d0 · Cited by 129
Options for Slowing the Growth of Health Care Costs
Mongan, J. J., Ferris, T. G. G., & Lee, T. H.-Y. (2008) · New England Journal of Medicine · doi:10.1056/nejmsb0707912 · Cited by 128
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
Mark, D. B., & Hlatky, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000021407.93752.7b · Cited by 128
Ware, J. H., & Antman, E. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371610 · Cited by 125
Halpern, E. F., Weinstein, M. C., Hunink, M. G. M., & Gazelle, G. S. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000308 · Cited by 115
Uncertainty in Decision Models Analyzing Cost-Effectiveness
Hunink, M. G. M., Bult, J. R., de Vries, J. A., & Weinstein, M. C. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800312 · Cited by 111
The value of medical spending in the United States.
Braithwaite, R. S., & Roberts, M. S. (2006) · PubMed · Cited by 110
Weintraub, W. S., Mahoney, E. M., Lamy, A. L., Culler, S. D., Yuan, Y., Caro, J. J., Gabriel, S., & Yusuf, S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.051 · Cited by 106
Schleinitz, M. D., & Heidenreich, P. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00007 · Cited by 98
Sanders, G. D., Hlatky, M. A., Every, N. R., McDonald, K. M., Heidenreich, P. A., Parsons, L. S., & Owens, D. K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-10-200111200-00007 · Cited by 86
Visualizing Cost-effectiveness Analysis
Mark, D. (2002) · JAMA · doi:10.1001/jama.287.18.2428 · Cited by 34
Cited by
The Economic Costs of Autism Spectrum Disorder: A Literature Review
Rogge, N., & Janssen, J. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04014-z · Cited by 384
Fearon, W. F., Bornschein, B., Tonino, P. A. L., Gothe, R. M., Bruyne, B. D., Pijls, N. H. J., & Siebert, U. (2010) · Circulation · doi:10.1161/circulationaha.109.925396 · Cited by 366
Morgan-Bathke, M., Baxter, S. D., Halliday, T. M., Lynch, A., Malik, N., Raynor, H. A., Garay, J. L., & Rozga, M. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.03.014 · Cited by 54
Nguyen, T. M., Tonmukayakul, U., Le, L. K.-D., Calache, H., & Mihalopoulos, C. (2023) · Applied Health Economics and Health Policy · doi:10.1007/s40258-022-00758-5 · Cited by 44
Moretto, N., Comans, T. A., Chang, A. T., O’Leary, S. P., Osborne, S., Carter, H. E., Smith, D., Cavanagh, T., Blond, D., & Raymer, M. (2019) · Implementation Science · doi:10.1186/s13012-019-0923-1 · Cited by 25
Metadata
- Authors
- Cohen, D. J., & Reynolds, M. R.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 52
- Issue
- 25
- Pages
- 2119-2126
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2063196635
- Cited by
- 302
- References
- 42
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.